Literature DB >> 11930334

Worldwide incidence of multidrug-resistant tuberculosis.

Christopher Dye1, Marcos A Espinal, Catherine J Watt, Cyrille Mbiaga, Brian G Williams.   

Abstract

Planning for tuberculosis (TB) control requires an assessment of the number and distribution of drug-resistant cases. This study used results of resistance surveys from 64 countries, together with data predictive of resistance rates from 72 others, to estimate the number of new multidrug-resistant (MDR) TB cases that occurred in 2000. By these methods, an estimated 273,000 (95% confidence limits, 185,000 and 414,000) new cases of MDR TB occurred worldwide in 2000, 3.2% of all new TB cases. The analysis provides the first comprehensive set of estimates of the MDR TB burden by country and globally.

Entities:  

Mesh:

Year:  2002        PMID: 11930334     DOI: 10.1086/339818

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  56 in total

1.  Strong in vitro activities of two new rifabutin analogs against multidrug-resistant Mycobacterium tuberculosis.

Authors:  Ana-Belén García; Juan J Palacios; María-Jesús Ruiz; José Barluenga; Fernando Aznar; María-Paz Cabal; José María García; Natalia Díaz
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

2.  Mycobacterium tuberculosis PE25/PPE41 protein complex induces activation and maturation of dendritic cells and drives Th2-biased immune responses.

Authors:  Wei Chen; Yige Bao; Xuerong Chen; Jeremy Burton; Xueli Gong; Dongqing Gu; Youjun Mi; Lang Bao
Journal:  Med Microbiol Immunol       Date:  2015-08-30       Impact factor: 3.402

3.  Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.

Authors:  O S Toungoussova; A O Mariandyshev; G Bjune; D A Caugant; P Sandven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-03       Impact factor: 3.267

4.  Tuberculosis 2004: challenges and opportunities.

Authors:  Jeffrey Glassroth
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

5.  Role of surgery in pulmonary multidrug-resistant tuberculosis.

Authors:  L Peter Ormerod
Journal:  Thorax       Date:  2007-05       Impact factor: 9.139

Review 6.  Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis.

Authors:  Christopher Dye
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

7.  Association of strong immune responses to PPE protein Rv1168c with active tuberculosis.

Authors:  Nooruddin Khan; Kaiser Alam; Shiny Nair; Vijaya Lakshmi Valluri; Kolluri J R Murthy; Sangita Mukhopadhyay
Journal:  Clin Vaccine Immunol       Date:  2008-04-09

Review 8.  Tuberculosis: drug resistance, fitness, and strategies for global control.

Authors:  Erik C Böttger; Burkhard Springer
Journal:  Eur J Pediatr       Date:  2007-11-07       Impact factor: 3.183

9.  Drug-resistant tuberculosis in Shanghai, China, 2000-2006: prevalence, trends and risk factors.

Authors:  X Shen; K DeRiemer; Z-An Yuan; M Shen; Z Xia; X Gui; L Wang; Q Gao; J Mei
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

10.  Crystal structures of Mycobacterium tuberculosis KasA show mode of action within cell wall biosynthesis and its inhibition by thiolactomycin.

Authors:  Sylvia R Luckner; Carl A Machutta; Peter J Tonge; Caroline Kisker
Journal:  Structure       Date:  2009-07-15       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.